Caplight Directory>Companies>NuProbe-preview>Nuprobe


NuProbe

NuProbe

Private
Houston, TexasHealthcare & Life Scienceshttps://www.nuprobe.com

Last Round

Series C

Jun 2, 2022

Total Funding Raised

$103M

Company Overview

NuProbe is a healthcare technology company that specializes in precision diagnostic solutions for the early detection of cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

liquid biopsyBlocker Displacement AmplificationBDAmolecular diagnosticslow frequency mutation detectioncancer biomarker detectiononcology diagnosticscell-free DNAcfDNAminimal residual disease detectionMRD detectionNGS panelcustom assay developmenttechnology licensingQuantitative Amplicon SequencingQASeqCNV detectionnon-invasive prenatal testingNIPT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NuProbe Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NuProbe Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CJun 2, 2022
Series BJan 11, 2021
Series AApr 23, 2018
View all Funding Rounds

NuProbe Investors

Notable investors and investment history

InvestorRounds
BioTrack CapitalSeries C, Series B
Pappas CapitalSeries C
Shanghai Deguan Asset ManagementSeries B
CEC Capital GroupSeries B
Sequoia CapitalSeries A
Yonghua CapitalSeries C, Series B
Serica PartnersSeries B, Series A
View all Investors

NuProbe Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NuProbe Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NuProbe's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range25
Year Founded2016
Last FundingJun 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.